The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Self-reported quality-of-life (QoL) impairment and productivity loss in patients with polycythemia vera (PV) enrolled in the REVEAL study.
 
Michael Richard Grunwald
Stock and Other Ownership Interests - Medtronic
Consulting or Advisory Role - Alexion Pharmaceuticals; Incyte
Research Funding - Amgen (Inst); FORMA Therapeutics (Inst); Incyte (Inst); Janssen (Inst)
 
Ralph V. Boccia
Honoraria - Incyte
 
Alison Moliterno
Consulting or Advisory Role - Incyte
 
Brady Stein
Consulting or Advisory Role - Incyte
 
Stephen T. Oh
Consulting or Advisory Role - Gilead Sciences; Incyte
Speakers' Bureau - Incyte
Research Funding - CTI (Inst); Gilead Sciences (Inst); Incyte (Inst)
 
Ahmad Bilal Naim
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Joseph A. Cordaro
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Wei Peng
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Hao Sun
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Shreekant Parasuraman
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Ruben A. Mesa
Honoraria - AOP Orphan Pharmaceuticals; Novartis; shire
Consulting or Advisory Role - Baxalta; Galena Biopharma
Research Funding - CTI (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); NS Pharma (Inst); Pfizer (Inst); Pharmaessentia (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; Incyte; Novartis